(Q43886162)

27 November 2017

Structure-based design of cyclooxygenase-2 selectivity into ketoprofen (English)

1 reference

27 November 2017

1 reference

6

1 reference

27 November 2017

Albert Palomer

1

1 reference

27 November 2017

Jaume Pascual

2

1 reference

27 November 2017

Marta Cabré

3

1 reference

27 November 2017

Liset Borràs

4

1 reference

27 November 2017

Gracia González

5

1 reference

27 November 2017

Assumpta Carabaza

7

1 reference

27 November 2017

Francesc Cabré

8

1 reference

27 November 2017

M Luisa García

9

1 reference

27 November 2017

David Mauleón

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

1 reference

27 November 2017

12

1 reference

27 November 2017

4

1 reference

27 November 2017

533-537

1 reference

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Modeling cyclooxygenase inhibition. Implication of active site hydration on the selectivity of ketoprofen analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Structure-based design of COX-2 selectivity into flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Comparative molecular modeling study of the three-dimensional structures of prostaglandin endoperoxide H2 synthase 1 and 2 (COX-1 and COX-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900800-9

7 January 2021

10.1016/S0960-894X(01)00800-9

Identifiers

DOI

1 reference

27 November 2017

1 reference